A randomized, controlled clinical trial was IRB Approved on July 2nd 2019 for the UroGold100 SoftWave device.

Tissue Regeneration Technologies: 251 Heritage Walk Woodstock, GA 30188|(404) 402-6844

A randomized, controlled clinical trial was IRB Approved on July 2nd 2019 for the UroGold100 SoftWave device.

7/8/2019

The study will commence immediately at the prestigious SDSM Clinic in San Diego, with former AUA and ISSM president Dr Irwin Goldstein as the investigator. The protocol was designed and will be managed by Sue Goldstein. Enrollment with commence immediately and additional centers recruited from the country's top research centers.

Comments are closed.

Specializing in sales of medical devices using our patented acoustic wave technology to profoundly accelerate healing and recoveries for the human body.

251 Heritage Walk
Woodstock, GA 30188
info@trtllc.com
(888) 862-6162

Investors
About
Treatment Locations
Cardiology
Dermatology
Lithotripsy
Orthopedics
Veterinary
Wound Care
Research
News
Results
Patents
Device Specs
Tech Training
Contact Us

TRT's OrthoGold 100 is FDA cleared for the activation of connective tissue, and FDA Registered for pain reduction
and improved blood supply.

A randomized, controlled clinical trial was IRB Approved on July 2nd 2019 for the UroGold100 SoftWave device.

Please join our quarterly newsletter.